Literature DB >> 16343850

A comparison of tongue and soft palate squamous cell carcinoma treated by primary surgery in terms of survival and quality of life outcomes.

J S Brown1, S N Rogers, D Lowe.   

Abstract

In the surgical management of oral cancer the resection and reconstruction of the mobile tongue and soft palate are most important if function is to be maintained. The present trend towards primary laryngeal surgery for early disease has emphasized the importance of primary surgery if good functional outcomes can be achieved. This study compares the functional and health-related quality of life outcomes for primary surgery and reconstruction of the anterior tongue and soft palate. From a cohort of 566 patients treated from 1992 to 2002, 118 fitted the criteria for anterior tongue and 44 for soft palate resection. University of Washington Quality of Life scores were available in around three quarters of patients. In terms of speech and swallowing a 3/4 or total anterior glossectomy had a worse outcome than a 1/4 or 1/2. In patients having a 3/4 or total resection of the soft palate however, the results showed a similar outcome to those with 1/4 or 1/2 resection. The functional results of 3/4 and total soft palate reconstruction were superior to 3/4 and total anterior tongue resections and were similar to the whole cohort. This finding extends the role of functional surgery in the oropharynx for which primary radiotherapy is often preferred to preserve function.

Entities:  

Mesh:

Year:  2005        PMID: 16343850     DOI: 10.1016/j.ijom.2005.09.005

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  16 in total

1.  Swallowing, speech and quality of life in patients undergoing resection of soft palate.

Authors:  Lívia Fernandes Barata; Genival Barbosa de Carvalho; Elisabete Carrara-de Angelis; José Carlos Marques de Faria; Luiz Paulo Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-22       Impact factor: 2.503

Review 2.  The humanistic burden of head and neck cancer: a systematic literature review.

Authors:  Erika Wissinger; Ingolf Griebsch; Juliane Lungershausen; Michael Byrnes; Karin Travers; Chris L Pashos
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

3.  [Oropharynx reconstruction. Use of free and pedicled flaps].

Authors:  S Herberhold; F Bootz
Journal:  HNO       Date:  2013-07       Impact factor: 1.284

4.  Infrahyoid myofascial flap for tongue reconstruction.

Authors:  Jochen P Windfuhr; Stephan Remmert
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-26       Impact factor: 2.503

5.  Health related quality of life following the treatment of oropharyngeal cancer by transoral laser.

Authors:  S N Rogers; R S Pinto; J Lancaster; F Bekiroglu; D Lowe; S Tandon; T M Jones
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-18       Impact factor: 2.503

6.  Function-Preserving Neurotized Lateral Arm Free Flap in the Reconstruction of Hemiglossectomy Defects.

Authors:  Divya Prakash; T M Balakrishnan; J Jaganmohan
Journal:  Indian J Plast Surg       Date:  2021-06-23

7.  Preservation of organ function in head and neck cancer.

Authors:  Uta Tschiesner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

8.  Primary surgery versus chemoradiotherapy for advanced oropharyngeal cancers: a longitudinal population study.

Authors:  Daniel O'Connell; Hadi Seikaly; Russell Murphy; Charles Fung; Tim Cooper; Aaron Knox; Rufus Scrimger; Jeffrey R Harris
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-04-22

Review 9.  Levels of scientific evidence of the quality of life in patients treated for oral cancer.

Authors:  Rocío Barrios; Javier Montero; Miguel-Angel González-Moles; Pilar Baca; Manuel Bravo
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-07-01

10.  Plectin as a prognostic marker in non-metastatic oral squamous cell carcinoma.

Authors:  Oddveig G Rikardsen; Synnøve N Magnussen; Gunbjørg Svineng; Elin Hadler-Olsen; Lars Uhlin-Hansen; Sonja E Steigen
Journal:  BMC Oral Health       Date:  2015-08-26       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.